-
Frequently Asked Questions (FAQ) on Personalised Medicine and EP PerMed
This FAQ page provides a concise introduction to key concepts, current challenges, and ongoing European efforts to support the responsible and effective implementation of personalised medicine.
-
Transnational Strategies and Policy Papers related to Personalised Medicine
Personalised medicine is shaped by transnational initiatives that connect countries, infrastructures, research communities and policy agendas. This list brings together European and international strategies, roadmaps, declarations and policy papers that provide context for national and regional implementation.
-
Laws, Acts and other Legal Instruments related to Personalised Medicine
Personalised medicine depends not only on strategies, but also on legal and regulatory frameworks that shape data use, genomics, biobanking, patient rights, research governance and access to innovation. This list highlights legal instruments that are related to the implementation of personalised medicine in practice.
-
National and Regional Strategies Related to Personalised Medicine
Personalised medicine is being advanced through a growing number of national and regional strategies, programmes and implementation initiatives. This list brings together sources that show how countries and regions are setting priorities, building infrastructures and moving towards implementation of personalised medicine approaches.
-
Projects and Initiatives on Personalised Medicine
This list of projects and initiatives in personalised medicine is the output of a mapping activity that has involved all EP PerMed partners in a collective endeavour and represents a step forward in the rationalisation of initiatives on PM that are being carried out in the member states.
-
Country Health Profiles
The State of Health in the EU cycle is a two-year process initiated by the European Commission, designed to improve country-specific and EU-wide knowledge in the field of health. Experts from the Organisation for Economic Co-operation and Development (OECD) and the European Observatory on Health Systems and Policies (Observatory) prepared a set of 29 Country…
-
International Cooperation in Personalised Medicine
In the field of personalised medicine, international cooperation has tradition. PM dedicated European projects (also called “ICPerMed Family” projects) have initiated collaboration on international level with Latin-American Countries (EULAC PerMed), China (SINO-EU PerMed, IC2PerMed) and Africa (EU-Africa PerMed). EP PerMed will build upon these established links in order to continue the fruitful collaboration. Cooperation with…
-
Other PM-related Initiatives & Consortia
Initiatives with close collaboration ICPerMed & ICPerMed Family The International Consortium for Personalsied Medicine (ICPerMed) provides a platform to initiate and support communication and exchange on personalised medicine research, funding and implementation. The high level of participation from all over Europe and beyond enables ICPerMed to efficiently map the scientific and political landscape. ICPerMed works…
EUROPEAN PARTNERSHIP